AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

Beverley J. Shea, Barnaby C. Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson, David A. Henry

Research output: Contribution to journalArticleResearchpeer-review

281 Citations (Scopus)
136 Downloads (Pure)

Abstract

The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.

Original languageEnglish
Article numberj4008
JournalBMJ (Online)
Volume358
DOIs
Publication statusPublished - 2017

Fingerprint

Delivery of Health Care

Cite this

Shea, Beverley J. ; Reeves, Barnaby C. ; Wells, George ; Thuku, Micere ; Hamel, Candyce ; Moran, Julian ; Moher, David ; Tugwell, Peter ; Welch, Vivian ; Kristjansson, Elizabeth ; Henry, David A. / AMSTAR 2 : A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. In: BMJ (Online). 2017 ; Vol. 358.
@article{a86f02db14ec4db494f6687ae338ac2a,
title = "AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both",
abstract = "The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.",
author = "Shea, {Beverley J.} and Reeves, {Barnaby C.} and George Wells and Micere Thuku and Candyce Hamel and Julian Moran and David Moher and Peter Tugwell and Vivian Welch and Elizabeth Kristjansson and Henry, {David A.}",
year = "2017",
doi = "10.1136/bmj.j4008",
language = "English",
volume = "358",
journal = "BMJ (Clinical research ed.)",
issn = "0959-535X",
publisher = "BMJ Publishing Group",

}

Shea, BJ, Reeves, BC, Wells, G, Thuku, M, Hamel, C, Moran, J, Moher, D, Tugwell, P, Welch, V, Kristjansson, E & Henry, DA 2017, 'AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both' BMJ (Online), vol. 358, j4008. https://doi.org/10.1136/bmj.j4008

AMSTAR 2 : A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. / Shea, Beverley J.; Reeves, Barnaby C.; Wells, George; Thuku, Micere; Hamel, Candyce; Moran, Julian; Moher, David; Tugwell, Peter; Welch, Vivian; Kristjansson, Elizabeth; Henry, David A.

In: BMJ (Online), Vol. 358, j4008, 2017.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - AMSTAR 2

T2 - A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

AU - Shea, Beverley J.

AU - Reeves, Barnaby C.

AU - Wells, George

AU - Thuku, Micere

AU - Hamel, Candyce

AU - Moran, Julian

AU - Moher, David

AU - Tugwell, Peter

AU - Welch, Vivian

AU - Kristjansson, Elizabeth

AU - Henry, David A.

PY - 2017

Y1 - 2017

N2 - The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.

AB - The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.

UR - http://www.scopus.com/inward/record.url?scp=85029833812&partnerID=8YFLogxK

U2 - 10.1136/bmj.j4008

DO - 10.1136/bmj.j4008

M3 - Article

VL - 358

JO - BMJ (Clinical research ed.)

JF - BMJ (Clinical research ed.)

SN - 0959-535X

M1 - j4008

ER -